Individualizing Therapy for Metastatic Colorectal Cancer
A Report from ASCO 2007 First-Line Metastatic Colorectal Cancer
【輸入盤CD】【新品】Afterhours / Folfiri O Folfox【K2016/6/17発売】
Novel treatment strategies in metastatic colorectal cancer patients with KRAS wildtype tumors
PANDA study demonstrates progression-free survival gain for FOLFOX + panitumumab and 5FU / LV + first-line panitumumab to RAS-BRAF wild-type elderly metastatic colorectal cancer patients